Drug Profile
Staphylococcus aureus toxoid bivalent vaccine - Integrated BioTherapeutics
Alternative Names: LukVaxLatest Information Update: 28 Jul 2020
Price :
$50
*
At a glance
- Originator Integrated BioTherapeutics
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Staphylococcal infections
Most Recent Events
- 28 Jul 2020 No recent reports of development identified for preclinical development in Staphylococcal-infections in USA (Parenteral)